All issues > Volume 44(8); 2001

Case Report

J Korean Pediatr Soc. 2001;44(8):942-947. Published online August 15, 2001.

Two Cases of Growth Hormone Therapy in Idiopathic Dilated Cardiomyopath

Jeong Won JW Shin¹, Hong Ryang HR Kil¹, Jae Hong JH Yu¹

¹Department of Pediatrics, College of Medicine, Chungnam National University, Daejon, Korea

Correspondence Jae Hong JH Yu ,Email: jhongyu@cuvic.cnu.ac.kr

Abstract

Growth hormone receptor gene is expressed in the myocardium and growth hormone(GH) administration has been shown to increase cardiac insulin-like growth factor-I(IGF-1) contents. The cardiac myocyte express IGF-I receptors and IGF-I promotes cardiac hypertrophy. Furthermore GH therapy has been reported to have beneficial effects in the treatment of dilated cardiomyopathy in adults. We have studied the effect of short term growth hormone treatment in two cases of a 5 year-old girl and a 15 year-old boy presenting idiopathic dilated cardiomyopathy. Transthoracic echocardiography revealed that the left ventricular chamber was markedly dilated and the global left ventricular systolic function was severely reduced in both. Medical treatments such as inotropic agents, diuretics and angiotensin converting enzyme(ACE) inhibitor were tried but we could not attain remarkable improvement. Finally, we started growth hormone treatment (0.35 U/kg/week, Eutropin, LGCI, Korea) and after treatment for 3 months, we attained a remarkable hemodynamic improvement in the 5 year-old girl with remarkable IGF-I increase after GH treatment, but not in the 15 year-old boy without IGF-I increase. The treatment was safe without side effects. However, no beneficial effects on cardiac function or structure were detected at 6 months of post-treatment.

Keywords :Idiopathic dilated cardiomyopathy, Growth hormone therapy